Pinar Uysal-Onganer

Dr. Pinar Uysal-Onganer

University of Westminster
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
Pinar Uysal-OnganerPinar Uysal-Onganer
Pinar Uysal-Onganer
YKYoshiaki Kawano
Yoshiaki Kawano
MCMercedes Caro
Mercedes Caro
MWMarjorie M Walker
Marjorie M Walker
SDSoraya Diez
Soraya Diez
Robert KyptaRobert Kypta
Robert Kypta
Wnt-11 is a secreted protein that modulates cell growth, differentiation and morphogenesis during development. We previously reported that Wnt-11 expression is elevated in hormone-independent prostate cancer and that the progression of prostate cancer from androgen-dependent to androgen-independent proliferation correlates with a loss of mutual inhibition between Wnt-11- and androgen receptor-dependent signals. However, the prevalence of increased expression of Wnt-11 in patient tumours and the functions of Wnt-11 in prostate cancer cells were not known.

1 October 2006 in Cancer Letters
Verified
Journal Article
Closed access
EAEbru Aydar
Ebru Aydar
Pinar Uysal-OnganerPinar Uysal-Onganer
Pinar Uysal-Onganer
RPRebecca Perrett
Rebecca Perrett
MDMustafa B. Djamgoz
Mustafa B. Djamgoz
CPChristopher P. Palmer
Christopher P. Palmer

4 June 2020 in Viruses
Verified
Journal Article
Open access
PDF file
EAElif Damla Arisan
Elif Damla Arisan
ADAlwyn Dart
Alwyn Dart
GGGuy H. Grant
Guy H. Grant
SASerdar ARISAN
Serdar ARISAN
SCSongul Cuhadaroglu
Songul Cuhadaroglu
Pinar Uysal-OnganerPinar Uysal-Onganer
Pinar Uysal-Onganer
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a member of the betacoronavirus family, which causes COVID-19 disease. SARS-CoV-2 pathogenicity in humans leads to increased mortality rates due to alterations of significant pathways, including some resulting in exacerbated inflammatory responses linked to the “cytokine storm” and extensive lung pathology, as well as being linked to a number of comorbidities. Our current study compared five SARS-CoV-2 sequences from different geographical regions to those from SARS, MERS and two cold viruses, OC43 and 229E, to identify the presence of miR-like sequences. We identified seven key miRs, which highlight considerable differences between the SARS-CoV-2 sequences, compared with the other viruses. The level of conservation between the five SARS-CoV-2 sequences was identical but poor compared with the other sequences, with SARS showing the highest degree of conservation. This decrease in similarity could result in reduced levels of transcriptional control, as well as a change in the physiological effect of the virus and associated host-pathogen responses. MERS and the milder symptom viruses showed greater differences and even significant sequence gaps. This divergence away from the SARS-CoV-2 sequences broadly mirrors the phylogenetic relationships obtained from the whole-genome alignments. Therefore, patterns of mutation, occurring during sequence divergence from the longer established human viruses to the more recent ones, may have led to the emergence of sequence motifs that can be related directly to the pathogenicity of SARS-CoV-2. Importantly, we identified 7 key-microRNAs (miRs 8066, 5197, 3611, 3934-3p, 1307-3p, 3691-3p, 1468-5p) with significant links to KEGG pathways linked to viral pathogenicity and host responses. According to Bioproject data (PRJNA615032), SARS-CoV-2 mediated transcriptomic alterations were similar to the target pathways of the selected 7 miRs identified in our study. This mechanism could have considerable significance in determining the symptom spectrum of future potential pandemics. KEGG pathway analysis revealed a number of critical pathways linked to the seven identified miRs that may provide insight into the interplay between the virus and comorbidities. Based on our reported findings, miRNAs may constitute potential and effective therapeutic approaches in COVID-19 and its pathological consequences.

1 November 2005 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
Pinar Uysal-OnganerPinar Uysal-Onganer
Pinar Uysal-Onganer
MSM J Seckl
M J Seckl
Prof. Dr. Mustafa DjamgozProf. Dr. Mustafa Djamgoz
Prof. Dr. Mustafa Djamgoz
Wide ranging experimental evidence suggests that human small-cell lung cancer (SCLC) has a number of molecular and subcellular characteristics normally associated with neurones. This review outlines and discusses these characteristics in the light of recent developments in the field. Emphasis is placed upon neuronal cell adhesion molecules, neurone-restrictive silencer factor, neurotransmitters/peptides and voltage-gated ion, especially Na+ channels. The hypothesis is put forward that acquisition of such characteristics and the membrane ‘excitability’ that would follow can accelerate metastatic progression. The clinical potential of the neuronal characteristics of SCLC, in particular ion channel expression/activity, is discussed in relation to possible novel diagnostic and therapeutic modalities.

7 May 2011 in Acta Physiologica
Verified
Journal Article
Closed access
Pinar Uysal-OnganerPinar Uysal-Onganer
Pinar Uysal-Onganer
Robert KyptaRobert Kypta
Robert Kypta